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Abstract The oxythiamine (OXY) is antivitamin of thia-
mine. The finding that OXY increases the cytoplasmic
concentration of pyruvate, known to enhance collagen
biosynthesis, led us to investigate the mechanism of this
antivitamin action on collagen biosynthesis in cultured
human skin fibroblasts. Confluent fibroblasts were treated
with micromolar concentrations (30–1,000 lM) of OXY
for 24 and 48 h. It was found that OXY-dependent increase
in collagen biosynthesis was accompanied by parallel
increase in prolidase activity and level, compared to
untreated cells. Since phosphoenolpyruvate (PEP) is known
as an inhibitor of prolidase—the enzyme that plays impor-
tant role in collagen biosynthesis, the mechanism of pyru-
vate interconversion was considered as a regulatory switch
in collagen biosynthesis. In fact, 3-MPA, specific inhibitor
of phosphoenolpyruvate carboxykinase (PEPCK), contrib-
uted to up-regulation of prolidase activity, suggesting that
down-regulation of PEP formation is an underlying mech-
anism. Since collagen biosynthesis and prolidase activity
are regulated by signal induced by activated a2b1 integrin
receptor as well as insulin-like growth factor-I receptor
(IGF-IR), the expression of these receptors was measured
by Western immunoblot analysis. The exposure of the cells
to OXY contributed to decrease in IGF-IR, a2b1 integrin
receptor, pERK1/2, and NF-jB p65 expressions. It was
accompanied by increase in total ERK1/2 expression and
induction of phosphorylation of Akt protein. The data
suggest that OXY-dependent increase of collagen biosyn-
thesis in cultured human skin fibroblasts results from acti-
vation of prolidase activity and level, induction in pAkt
expression and down-regulation of pERK1/2 and NF-jB
p65, the known inhibitor of collagen gene expression.
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Introduction
Oxythiamine (OXY) is antivitamin of thiamine. It interferes
with the enzymes of thiamine pyrophosphate-dependent
pathways and can inhibit conversion of glucose into pentose
phosphate that is necessary for the synthesis of nucleotides
and metabolism of amino acids [1]. OXY increases the
amount of pyruvate by inhibition of pyruvate decarboxylase
[2]. Pyruvate has a key position in several metabolic path-
ways such as glycolysis and gluconeogenesis. Inhibition of
pyruvate decarboxylase, which is part of the pyruvate
dehydrogenase complex may interfere with the course of the
oxidative decarboxylation of pyruvate. The result of this
phenomenon is accumulation of pyruvate in the cell.
It was documented that pyruvate enhances collagen
biosynthesis in slices of liver of cirrhotic rats [3]. The role
of OXY in collagen biosynthesis, however, is not known.
It was also found that in the presence of oxythiamine the
activity of cytosolic enzymes, transketolase, and pyruvate
decarboxylase was down and up-regulated, dependently on
time of incubation. At least in case of pyruvate decarbox-
ylase, increase in the enzyme activity was followed by an
increase in the amount of the enzyme protein [4], sug-
gesting transcriptional regulation.
Since PEP is known as an inhibitor of prolidase—the
enzyme that play important role in collagen biosynthesis,
the mechanism of pyruvate interconversion may represent
regulatory switch in collagen biosynthesis.
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Prolidase [EC 3.4.13.9] is a cytosolic enzyme that cat-
alyzes the hydrolysis of imidodipeptides with C-terminal
proline or hydroxyproline [5–7]. The enzyme plays an
important role in the recycling of proline from imidodi-
peptides (derived from degradation products of collagen)
for collagen re-synthesis [8] and cell growth [9]. The
efficiency of recycling of proline was found to be about
90 % [10]. It is evident that an absence of prolidase
severely impedes the recycling of collagen proline. Some
clinical symptoms related to collagen deficit can be
attributed to prolidase deficiency [11]. On the other hand,
increased activity of liver prolidase was found during
fibrotic process [12]. It suggests that the enzyme activity
(despite the collagen gene expression) may be a step-lim-
iting factor in regulation of collagen biosynthesis. It has
been supported by several studies [13–16].
Prolidase activity is stimulated through a signal mediated
by collagen-b1 integrin receptor interaction [17, 18]. On the
other hand, prolidase activity ‘‘in vitro’’ is inhibited by a
strong, competitive inhibitor, PEP, that arises from pyruvate
[19, 20].
Another factor that strongly stimulates collagen bio-
synthesis is insulin-like growth factor-I (IGF-I), acting
predominantly through the IGF-I receptor [21, 22]. The
effects of IGF-I include induction of collagen gene
expression [23], up-regulation of prolidase activity [24],
stimulation of mitotic division and prevention of apoptosis
[21]. Some of these activities are regulated through NF-jB,
the known inhibitor of collagen gene expression [25].
In this study, we examined the effect of OXY on cell
viability, collagen biosynthesis, prolidase activity and
level, expression of a2b1 integrin, IGF-I receptor, MAP
kinases (ERK1, ERK2), Akt protein, and the transcription
factor—NF-jB p65 in human dermal fibroblasts.
Materials and methods
Alkaline phosphatase-labeled anti-mouse IgG and anti-rab-
bit IgG antibodies, bacterial collagenase, 3-(4,5-di-methyl-
thiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
Fast BCIP/NBT reagent, L-glycyl-proline, L-proline, mono-
clonal (mouse) anti-IGF-IR, anti-pERK1/2 and polyclonal
(rabbit) anti-b-actin antibodies, sodium pyruvate, and oxy-
thiamine, were provided by Sigma Corp., USA., as were
most other chemicals and buffers used. Dulbecco’s minimal
essential medium (DMEM) and fetal bovine serum (FBS)
used in cell culture were products of Gibco, USA. Gluta-
mine, penicillin, and streptomycin were obtained from
Quality Biological Inc., USA. Nitrocellulose membrane
(0.2 lm), sodium dodecyl sulphate (SDS), polyacrylamide,
molecular weight standards, and Coomassie Brilliant Blue
R-250 were received from Bio-Rad Laboratories, USA.
L-5[3H] proline (28 Ci/mmol) was purchased from Amer-
sham, UK. Monoclonal (mouse) anti-b1 and polyclonal
(rabbit) anti-a2-integrin and anti-NFjB p65 antibodies were
the products of Santa Cruz Biotechnology Inc., USA. Poly-
clonal (rabbit) anti-ERK1/2 and monoclonal (rabbit) anti-
pAkt antibodies were the products of Cell Signaling Inc.,
USA. Polyclonal anti-human prolidase antibody was dona-
ted by Dr. James Phang (NCI-Frederick Cancer Research
and Development Center, Frederick, MD, USA). 3-mer-
captopicolinic acid (3-MPA) was purchased from Appli-
chem GmbH, Germany.
Tissue culture
All studies were performed on normal human skin fibro-
blasts (CRL-1474), that were purchased from American
Type Culture Collection, Manassas, VA, USA. The cells
were maintained in DMEM supplemented with 10 % fetal
bovine serum (FBS), 2 mmol/l glutamine, 50 U/ml peni-
cillin, and 50 lg/ml streptomycin at 37 C in a 5 % CO2
incubator. Cells were counted in hemocytometer and cul-
tured at 1 9 105 cells per well in 2 ml of growth medium
in 6-well plates (Costar). Cells reached confluence at day 6
and in most cases such cells were used for assays. Cells
were used in the 8th to 14th passages.
Cell viability assay
The assay was performed according to the method of
Carmichael [26] using 3-(4,5-di-methylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). The cells were cul-
tured for 24 and 48 h with various concentrations of OXY
in six-well plates, washed three times with PBS, and then
incubated for 4 h in 1 ml of MTT solution (0.5 mg/ml of
PBS) at 37 C. The medium was removed, and 1 ml of
0.1 mol/l HCl in absolute isopropanol was added to
attached cells. Absorbance of converted dye in living cells
was measured at a wavelength of 570 nm. OXY-treated
cells viability was calculated as a percent of control cells.
Determination of prolidase activity
The activity of prolidase was determined according to the
method of Myara [27]. Protein concentration was measured
by the method of Lowry [28]. Enzyme activity was
reported as nanomoles of proline released from synthetic
substrate, during 1 min per milligram of supernatant pro-
tein of cell homogenate.
Collagen production
Incorporation of radioactive precursor into proteins was
measured after labeling of confluent cells (cultured in growth
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medium with OXY) for the last 24 h with 5[3H] proline
(5 lCi/ml, 28 Ci/mM) as described previously [29]. Incor-
poration of tracer into collagen was determined by digesting
proteins with purified Clostridium histolyticum collagenase,
according to the method of Peterkofsky [30]. Results are
shown as combined values for cell plus medium fractions.
SDS-PAGE
Slab SDS/PAGE was used according to the method of
Laemmli [31], using 10 % SDS-polyacrylamide gel.
Western Immunoblot Analysis
After SDS-PAGE, the gels were allowed to equilibrate for
5 min in 25 mmol/l Tris, 0.2 mol/l glycine in 20 % (v/v)
methanol. The protein was transferred to 0.2 lm pore-sized
nitrocellulose at 100 mA for 1 h using a LKB 2117 Multi-
phor II electrophoresis unit. The nitrocellulose was incu-
bated with monoclonal anti-b1 and polyclonal anti-a2-
integrin antibodies at concentration 1:1,000; polyclonal
antibodies against NFjB p65, ERK1/2, and b-actin at con-
centration 1:3,000; polyclonal antibody against prolidase at
concentration 1:5,000; monoclonal anti-IGF-IR, pERK1/2
and pAkt antibodies at concentration 1:1,000 in 5 % dried
milk in TBS-T (20 mmol/l Tris–HCl buffer, pH 7.4, con-
taining 150 mmol/l NaCl and 0.05 % Tween 20) for 1 h. In
order to analyze b1 integrin subunit, IGF-IR, and pERK1/
2 second antibody, alkaline phosphatase-conjugated anti-
mouse IgG (whole molecule) was added at concentration
1:7,500 in TBS-T; in order to analyze prolidase, a2-integrin
subunit, ERK1/2, pAkt, NFjB p65, and b-actin second
antibody, alkaline phosphatase-conjugated anti-rabbit IgG
(whole molecule) was added at concentration 1:5,000 in
TBS-T and incubated for 30 min slowly shaking. Then
nitrocellulose was washed with TBS-T (5 9 5 min) and
submitted to Sigma-Fast BCIP/NBT reagent. The intensity
of the bands was quantified by densitometric analysis.
Statistical Analysis
In all experiments, the mean values for three independent
experiments done in duplicates ± standard deviation (SD)
were calculated. The results were submitted to statistical
analysis using the Student’s t test, accepting P \ 0.01 as
significant.
Results
Studies were performed on confluent fibroblasts, since
collagen synthesis, prolidase activity as well as IGF-IR
expression depend on cell density [32, 33].
Since oxythiamine (OXY) was found to inhibit prolif-
eration of tumor cells [34–36], the cytotoxicity assay for
different doses of OXY in cultured human fibroblasts was
performed. Cell viability was measured by the method of
Carmichael et al. [26] using tetrazolium salt. The viability
of OXY-treated fibroblasts is presented in Fig. 1a. OXY at
studied concentrations did not influence the viability of the
cells at 24 and 48 h incubation.
Collagen biosynthesis and prolidase activity were mea-
sured in confluent human dermal fibroblasts that have been
treated with 30, 100, 300, and 1,000 lM of OXY. As can
be seen in Fig. 1b, 24 and 48 h incubation of confluent
fibroblasts in the medium containing 10 % of FBS and
different concentrations of OXY contributed to increase in
collagen biosynthesis in a dose-dependent manner.
1,000 lM OXY-induced increase in collagen biosynthesis
by about 36 % of control, after 24 h incubation and by
about 14 % of control after 48 h (Fig. 1b).
The mechanism of increase in collagen biosynthesis in
OXY-treated cells may be due to the accumulation of
pyruvate in the cell [2, 3]. This led us to investigate the
influence of pyruvate on this process. Unexpectedly, we
found that an addition of different concentrations of
pyruvate (1, 3, 10, 20 mM) contributed to reduce in col-
lagen biosynthesis. At concentration of 20 mM, pyruvate-
induced decrease in collagen biosynthesis to about 50 % of
control, after 24 h incubation (Fig. 1c).
To explain the mechanism of OXY-dependent increase in
collagen biosynthesis, we considered prolidase as a target
enzyme. Increase in collagen biosynthesis in OXY-treated
cells was accompanied by increase in prolidase activity by
about 57 and 14 % after 24 h and 48 h incubation, respec-
tively, compared to control (Fig. 2a). An increase in proli-
dase activity was accompanied by increase in the level of the
enzyme protein, by about 141 and 41 % after 24 and 48 h
incubation, respectively, compared to control, as shown by
Western immunoblot analysis (Fig. 2b, c).
The data show that OXY increases collagen biosynthesis
in skin fibroblasts and suggest that an increase may result
from stimulation of prolidase activity and expression.
We considered whether pyruvate or PEP is involved in
OXY-dependent regulation of collagen biosynthesis.
3-MPA is an inhibitor of phosphoenolpyruvate carboxy-
kinase (PEPCK). The enzyme is responsible for the con-
version of oxaloacetate to PEP. We decided to check if
inhibition of PEP formation can cause up-regulation of
collagen biosynthesis and prolidase activity. In previous
studies, we found that PEP down-regulate b1 integrin and
IGF-I receptors signaling providing mechanism for inhi-
bition of collagen biosynthesis in fibroblast. Moreover, we
found that there is no direct correlation between collagen
biosynthesis and prolidase activity and the enzyme level
[19].
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Therefore, the question was addressed whether an inhibitor
of PEPCK, 3-mercaptopicolinate (3-MPA) affects oxythi-
amine-induced prolidase activity. As described previously,
prolidase activity is stimulated by serum-derived growth
factors [37]. Therefore, activity of this enzyme was measured
in confluent fibroblasts, cultured for 1, 6, and 24 h in the
medium containing 0.1 % of fetal bovine serum (FBS), 1 mM
of 3-MPA, and different concentrations of OXY. The results
were compared to the cells cultured for 1 h, 6 h, and 24 h in
the medium containing 10 % FBS, 1 mM 3-MPA, and OXY.
As can be seen in Fig. 3a and c, 1 and 24 h incubation of
fibroblasts in the medium containing 0.1 % FBS and 1 mM
OXY-induced prolidase activity, by about 40 and 30 %,
respectively. However, 6 h incubation under the same
conditions contributed to decrease in prolidase activity to
70 % of control (Fig. 3b). The mechanism of this phe-
nomenon may involve PEP accumulation that inhibits
prolidase activity and collagen biosynthesis.
An addition of 1 mM of 3-MPA under the same con-
ditions contributed to increase in prolidase activity by
Fig. 1 Viability a of confluent
human skin fibroblasts
incubated for 24 and 48 h with
different concentrations of
oxythiamine (OXY). The mean
values ± SD from three
independent experiments done
in duplicates are presented.
*P B 0.01. Collagen
biosynthesis measured as 5[3H]
proline incorporation into
proteins susceptible to the
action of bacterial collagenase
in fibroblasts treated for 24 and
48 h with different
concentrations of (OXY) (b)
and sodium pyruvate (c). The
results present the mean values
from 6 assays ± SD *P B 0.01
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about 86 and 48 % at 1 and 6 h incubation, and had no
effect on prolidase activity after 24 h incubation. It may
suggest that decreased activity of PEPCK contributes to
suppression of PEP production (competitive inhibitor of
prolidase activity) [20] and may be responsible for increase
in the enzyme activity in first 6 h of incubation (Fig. 5,
graphical abstract).
As can be seen in Fig. 3a and c, 1 and 24 h incubation of
fibroblasts in the medium containing 10 % FBS and 1 mM
OXY-induced prolidase activity, by about 55 and 27 % of
control, respectively. After 6 h incubation, 100, 300, and
1,000 lM OXY increased prolidase activity by about 155,
63, and 13 % of control, respectively (Fig. 3b).
An addition of 1 mM of 3-MPA under the same con-
ditions had small effect on prolidase activity after 1 and 6 h
of incubation (increase by 8 and 5 % of control values,
Fig. 3a, b) and contributed to increase in enzyme activity
by about 22 % after 24 h incubation. In such conditions,
we observed that PEPCK decreased prolidase activity
(increased by OXY) after 1, 6, and 24 h incubation. It
suggests that decreased activity of PEPCK contributes to
suppression of PEP production (competitive inhibitor of
prolidase activity) [20] and is responsible for slight
increase in the enzyme activity (Fig. 5, graphical abstract).
Collagen biosynthesis and prolidase activity were pre-
viously shown to be regulated due to the signal induced by
activated a2b1 integrin receptor [17] as well as IGF-IR [12,
24]. Therefore, the expression of a2b1 integrin receptor
(receptor for type I collagen) and IGF-IR was measured by
Western immunoblot analysis. As can be seen in Fig. 4a,
24 and 48 h treatment of fibroblasts with 30, 100, 300 and
1,000 lM of OXY contributed to a distinct decrease in the
expression of a2 integrin subunit to about 94, 81, 79, and
46 % respectively, at 24 h, and to about 84, 75, 72, and
67 %, respectively, at 48 h, compared to the control cells.
24 and 48 h treatment of fibroblasts with 1,000 lM of
OXY reduced expression of b1 integrin subunit to about 79
and 85 %, respectively, compared to the control (Fig. 4b).
As shown in Fig. 4c, IGF-I receptor expression was
decreased for 1,000 lM OXY-treated cells to about 76 and
82 % at 24 and 48 h incubation, respectively, compared to
the control cells. We found that the highest concentration
of OXY decreases expression of phosphorylated ERK1/2 to
about 64 and 81 % at 24 and 48 h incubation, respectively
Fig. 2 Prolidase activity a in
confluent human skin fibroblasts
incubated in the medium
containing 10 % FBS and
different concentrations of
OXY. The results present the
mean values from 6
assays ± SD *P B 0.01.
Western blot analysis for
prolidase in fibroblasts
incubated 24 h (b) and 48 h
(c) with different concentrations
of OXY. The mean values of six
pooled cell homogenate extracts
from six separate experiments
are presented. The intensity of
the bands was quantified by
densitometric analysis.
Densitometry was done with
BioSpectrum Imaging System
and presented as arbitrary units
above the bands. 20 lg of
supernatant protein was run in
each lane for prolidase and b-
actin. The expression of b-actin
served as a control for protein
loading (d)
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(Fig. 4d) and stimulates expression of total ERK1/2 by
about 14 % at 24 h and by about 36 % at 48 h, compared
with control (Fig. 4e). Simultaneously, 1,000 lM of OXY-
dependent stimulation of total ERK1/2 expressions
(Fig. 4e) was accompanied by similar induction of phos-
phorylation of Akt by about 19 and 20 % at 24 and 48 h
(Fig. 4f), suggesting that in the experimental conditions,
ERK1/2 and Akt proteins represent signaling molecules
that respond to OXY action.
On the other hand, we have found that in 24 h OXY-treated
cells there is decrease in the expression of NF-jB p65, the
known inhibitor of collagen gene expression [25], compared
to control cells (Fig. 4g). Opposite phenomenon was observed
after 48 h incubation with OXY. An increase in the expression
of NF-jB p65 can explain only slight increase in collagen
biosynthesis due to OXY action at this time (Fig. 1b).
In view of this data, it seems that OXY-dependent
increase in collagen biosynthesis may be a consequence of
increase in prolidase activity and the enzyme protein level,
increase in pAkt level, and inhibition of pERK1/2 and NF-
jB p65.
Discussion
Skin fibroblasts are connective tissue cells specialized in col-
lagen biosynthesis. For this reason, they are a good model for
studies of the effects of regulatory factors on collagen metab-
olism. Furthermore, fibroblasts would undergo aerobic gly-
colysis providing increased pyruvate/lactate that could then be
used for the mitochondrial TCA cycle, oxidative phosphory-
lation, and ATP production for anabolic stimulation.
Fig. 3 Prolidase activity in
confluent human skin fibroblasts
incubated for 1 h (a), 6 h
(b) and 24 h (c) in the medium
containing 0.1 % FBS or 10 %
FBS and 1 mM of
3-mercaptopicolinate (3-MPA),
and different concentrations of
OXY. The results present the
mean values from 6
assays ± SD *P B 0.01
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The data presented here show that OXY induces an
increase in collagen biosynthesis in human skin fibroblasts.
The increase in collagen biosynthesis was correlated with
an increase in prolidase activity and the enzyme protein
level. Our studies support the relationship between colla-
gen synthesis and prolidase activity. A similar relationship
was observed during the fibrotic process, where an increase
in prolidase activity was accompanied by an increase in
tissue collagen deposition [12]. The link between collagen
production and prolidase activity was also found in cul-
tured human skin fibroblasts treated with anti-inflammatory
drugs [13], during experimental aging of these cells [14],
fibroblasts chemotaxis [37] and cell surface integrin
receptor ligation [17]. However, the link between OXY-
dependent accumulation of pyruvate and up-regulation of
collagen biosynthesis is not fully understood. Previously,
we proposed that the mechanism may originate at the level
of interconversion of pyruvate/PEP.
Oxythiamine (OXY) affects pentose phosphate path-
ways [35] and by inhibition of pyruvate decarboxylase
increases the amount of pyruvate [2]. Pyruvate is converted
into PEP by PEPCK catalyzing phosphorylation and con-
comitant decarboxylation of oxaloacetate. This reaction is
the first step of the gluconeogenic pathway, which is sub-
ject to regulation. PEP is known as a strong, competitive
inhibitor of prolidase activity ‘‘in vitro’’ [20]. In our pre-
vious study, we found that PEP contributed to decrease in
collagen biosynthesis in cultured human skin fibroblasts
through depression of a2b1 integrin and IGF-IR signaling.
However, we suggest that there is no direct correlation
Fig. 4 Western blot analysis
for a2-integrin (a), b1-integrin
(b) receptor subunits, IGF-I
receptor (c), pERK1/2 (d),
ERK1/2 (e), pAkt (f), and NF-
jB p 65 (g) in control human
skin fibroblasts and cultured for
24 and 48 h in the medium
containing different
concentrations of OXY. The
mean values of six pooled cell
homogenate extracts from six
separate experiments are
presented. The intensity of the
bands was quantified by
densitometric analysis.
Densitometry was done with
BioSpectrum Imaging System
and presented as arbitrary units
b. The same amount of
supernatant protein (20 lg) was
run in each lane. The expression
of b-actin served as a control for
protein loading (h)
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between collagen biosynthesis and prolidase activity and
level [19].
We investigated whether pyruvate or PEP is involved in
OXY-dependent regulation of collagen biosynthesis. It is
apparent from our study that inhibitor of PEPCK up-reg-
ulated prolidase activity in different experimental condi-
tions. It suggests that decreased activity of PEPCK
contributes to suppression of PEP production (competitive
inhibitor of prolidase activity) [20] and is responsible for
slight increase in the enzyme activity. In certain experi-
mental conditions (6 h incubation), we found OXY-
dependent inhibition of prolidase activity resulted probably
from PEP accumulation. The potential mechanism of
OXY-dependent regulation of prolidase activity and col-
lagen biosynthesis is outlined in Fig. 5.
Collagen is known as a ligand for a2b1 integrin. Previ-
ously, it has been shown that b1-integrin receptor is
involved in signaling, which regulates collagen biosyn-
thesis [38] and prolidase activity [17, 39]. Another
important point of collagen biosynthesis regulation is at the
level of insulin-like growth factor-I receptor (IGF-IR).
IGF-I is one of the most potent collagen-stimulating factors
in collagen synthesizing cells [22]. Therefore, we consid-
ered b1 integrin and IGF-IR as a potential target in OXY-
induced increase of the above processes.
Our observations suggest that in fibroblasts OXY indu-
ces collagen biosynthesis independently of a2b1 integrin
receptor and IGF-IR expressions. Presumably, increase in
prolidase activity and level in fibroblasts due to OXY
action is a result of increase in ERK1/2 signaling and
stimulation of Akt, suggesting that in experimental condi-
tions ERK1/2 and Akt proteins represent signaling mole-
cules that respond to OXY action.
Several other studies suggest that prolidase-dependent
regulation of collagen biosynthesis may take place at the
transcriptional level. The transfection of colorectal cancer
cells with prolidase vector inhibited NF-jB p65 expression
[40], well-recognized inhibitor of expression of a1 and a2
subunits of type I collagen [25, 41, 42]. Another evidence
for the role of prolidase in regulation of NF-jB expression
provides experiment showing that inhibition of prolidase
activity by Cbz-Pro contributed to up-regulation of NF-jB
Fig. 5 Graphical abstract. In the experimental conditions (OXY-
treated cells for 24 h), there is up-regulation of AKT that contributes
to stimulation of collagen biosynthesis through activation of proli-
dase—an enzyme supporting proline for collagen biosynthesis and
down-regulation of NF-kB—transcription factor that inhibits collagen
type I gene expression. During that time, OXY directs pyruvate for
TCA cycle that eliminate gluconeogenesis and production of PEP—
inhibitor of prolidase activity. The net result is up-regulation of
collagen biosynthesis. However, 48 h incubation of the cells with
OXY may contribute to accumulation of oxaloacetate in mitochondria
and stimulation of gluconeogenesis that increases cytoplasmic
concentration of PEP—inhibitor of prolidase and consequently
collagen biosynthesis. This process may be augmented by inhibitory
effect of OXY on pentose cycle
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p65 expression in fibroblasts [40]. In fact, our data showed
that OXY-dependent increase in prolidase activity (by
about 57 % of control) and collagen biosynthesis (by about
36 % of control) is accompanied by decrease in the
expression of NF-jB p65, after 24 h incubation. During
48 h incubation of fibroblasts in medium, supplemented
with OXY prolidase activity and collagen biosynthesis was
not significantly increased (both by about 14 % of control)
and down-regulation of NF-jB p65 was not observed.
Although the link between up-regulation of AKT and
down-regulation of ERK1/2 and NF-jB in OXY-treated
cells is not known, it cannot be excluded that underlying
mechanism may also involve pentose cycle. OXY is known
as a transketolase inhibitor that may cause a severe defi-
ciency in high-energy phosphate bonds, contributing to
decrease in protein phosphorylation and cell cycle arrest
[36].
It has been demonstrated in many in vitro studies that
OXY inhibits cancer cell growth through suppression of the
cell cycle. However, the molecular mechanism of the
action is poorly understood. Some data suggested that in
pancreatic cancer cells OXY may specifically induce cell
cycle arrest through deactivation of the MAPK pathways,
without effects on NF-jB [43]. Whether such a mechanism
takes place in normal cells requires to be explored.
The data suggest that OXY may exert its effect on colla-
gen biosynthesis through stimulation of prolidase activity
and the enzyme protein level, pAkt level, and inhibition in
pERK1/2 and NF- jB p65 transcriptional activity.
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